January 2024 - Page 7 of 17

MondayJan 22, 2024 9:00 am

Growth in Domestic Violence Incidents Shows Opportunity for SuperCom Ltd. (NASDAQ: SPCB) Electronic Monitoring Suite

SuperCom Ltd. is a digital security solutions innovator focused on revolutionizing public safety around the world through the use of technology, data intelligence and complementary services SuperCom’s PureSecurity Suite is used in dozens of projects worldwide, mostly by governmental agencies, for electronic monitoring of criminal suspects and convicted offenders, including those involved in domestic violence cases One recent report noted that millions of people were affected by domestic violence in the United States during 2022. Additionally, a burgeoning number of cases were observed in the island nation of Jamaica during that year, leading to the implementation of a new protective…

FridayJan 19, 2024 2:56 pm

QualityStocksNewsBreaks – Mullen Automotive Inc.’s (NASDAQ: MULN) Majority-Owned Bollinger Motors Receives Orders Valued at ~$6M

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, today announced that its majority-owned Bollinger Motors has received vehicle orders for 40 B4, Class 4 EV trucks, valued at a total of approximately $6 million. According to the announcement, the company anticipates the 100% American-made Bollinger B4 chassis cab to begin production in mid-2024. The truck is expected to be eligible nationwide for a federal purchasing incentive of 30% of the cost of the vehicle, up to a total of $40,000, through the Inflation Reduction Act of 2022. The announcement noted that the purpose-built Bollinger B4 commercial trucks, which…

FridayJan 19, 2024 2:48 pm

QualityStocksNewsBreaks – Diamond Lake Minerals Inc. (DLMI) Featured in Fab World Today Article

Diamond Lake Minerals (OTC: DLMI), which specializes in the development and support of digital assets and SEC-registered security tokens, was featured in a recent article by Fab World Today. The piece discusses Diamond Lake Minerals’ commitment to a secure and transparent future, its goal to responsibly innovate and combine traditional businesses with the evolving landscape of digital assets, and its primary focus on developing and supporting SEC-registered security tokens, operating across various industries. The article highlights the company’s significant growth since Brian J. Esposito took over as CEO, its unique structure, as well as Esposito’s vision. The publication observed that…

FridayJan 19, 2024 1:58 pm

QualityStocksNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) CEO to Present at January Water Tower Research Fireside Chat

InMed Pharmaceuticals (NASDAQ: INM), a leader in the manufacturing, development and commercialization of rare cannabinoids and proprietary cannabinoid analogs, announced that CEO Eric A Adams will be participating in the upcoming Water Tower Research Fireside Chat Series. This month’s chat is scheduled to begin at 1 p.m. ET on Jan. 25, 2024. According to the announcement, topics discussed during the event will include an overview of InMed’s pharmaceutical pipeline in Alzheimer’s and ocular as well as a discussion about cannabinoids and their possible role in the treatment of Alzheimer’s. In addition, the chat will include a look at upcoming 2024…

FridayJan 19, 2024 1:45 pm

QualityStocksNewsBreaks – D-Wave Quantum Inc. (NYSE: QBTS) Appoints Former Secretary of Homeland Security to Board of Directors

D-Wave Quantum (NYSE: QBTS) (“D-Wave”), a leader in quantum computing systems, software, and services and the world’s first commercial supplier of quantum computers, has named former Secretary of the U.S. Department of Homeland Security Kirstjen Nielsen to its board of directors. A global expert and proven leader on security issues critical to the highest priorities of the United States, Secretary Nielsen has a vast background in enterprise risk, resiliency, cybersecurity and emerging threats. Secretary Nielsen has held a variety of domestic and international government roles, including serving as a key member of the White House Homeland Security Council, helping create…

FridayJan 19, 2024 12:47 pm

QualityStocksNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Names Seasoned Biotech Leader to Board of Directors

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, has appointed a biotech veteran to its board of directors. The company announced that Amy Mahery, a highly accomplished biopharmaceutical industry executive, will join the company’s board effective upon completion of financing. With more than 20 years of experience working with large and small companies in common and rare conditions, Mahery brings impressive expertise in the commercialization and launch of drugs in varied therapeutic areas, including oncology, neurology, and immunology, to her new responsibilities.…

FridayJan 19, 2024 9:45 am

Turbo Energy (NASDAQ: TURB) Pioneers AI-Powered Household Energy Storage Solution

Whilst the European Union has been hugely successful in growing its renewable energy generation capacity, the bloc’s energy storage infrastructure has yet to catch up Turbo Energy’s innovative product offering has sought to address this concern for households, providing consumers with an all-in-one AI-powered energy storage solution AI is playing an increasingly transformative role within advanced energy storage technologies, helping consumers optimize their energy usage and maximize savings During the depths of the European winter in 2022, renewable energy sources generated more of the EU’s energy than fossil fuels for the first time ever. Coal power usage fell by 11…

FridayJan 19, 2024 9:00 am

SenesTech Inc. (NASDAQ: SNES) Marks Entry into One of the Largest Pest Control Markets with Fruit Tree Limited’s Distribution Deal

SenesTech, a rodent fertility control expert, just marked its entry into Hong Kong, Macau, and potentially mainland China with its distribution agreement with Fruit Tree Limited This move marks a remarkable start to the 2024 calendar year while reflecting the company’s commitment to creating shareholder value It also opens SenesTech up to many exciting opportunities, among them market entry into what is arguably the largest pest control market on the planet SenesTech (NASDAQ: SNES), a rodent fertility control expert and the inventor of the only EPA-registered contraceptive for male and female rats, just marked its entry into Hong Kong and…

ThursdayJan 18, 2024 1:33 pm

QualityStocksNewsBreaks — Mullen Automotive Inc. (NASDAQ: MULN) Sporty Five RS Featured in Recent CarScoops Article

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, and its just-announced Five RS is being spotlighted by CarScoops. Mullen unveiled the high-performance version of its crossover at the Consumer Electronics Show (“CES”) in Las Vegas, and CarScoops notes that the model has an intriguing design, big performance claims and a production date set for late 2025. The article pointed out key features of Mullen’s latest offering, including its fast-charging capabilities, integrated infotainment system, artificial intelligence (“AI”)-based personal assistance called Persona, facial recognition technology and level 2+ driver assistance tech. “Although seeing EVs with impressive performance figures is nothing…

ThursdayJan 18, 2024 12:59 pm

QualityStocksNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Reaches Planned Enrollment Berubicin Study for the Treatment of GBM

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, has completed enrollment in its global potentially pivotal study evaluating Berubicin. According to the announcement, the study has enrolled 247 patients across 46 clinical trial sites in the United States, Italy, France, Spain and Switzerland. A novel anthracycline, Berubicin appears to be the first anthracycline to cross the blood-brain barrier for the treatment of glioblastoma multiforme (“GBM”), an aggressive and incurable form of brain cancer. The Berubicin study is a multicenter, open-label, randomized controlled study…

Site Search

Company Search

Month: January 2024